Buscar
01/09/2025
European Guideline (EuroGuiDerm) on atopic eczema: Living update
Wollenberg, A, Kinberger, M, Arents, B, Aszodi, N, Barbarot, S, Bieber, T, Brough, HA, Calzavara-Pinton, P, Christen-Zaech, S, Deleuran, M, Dittmann, M, Fosse, N, Gáspár, K, Gerbens, LAA, Gieler, U, Girolomoni, G, Gregoriou, S, Holland, S, Mortz, CG, Nast, A, Nygaard, U, Rehbinder, EM, Ring, J, Rossi, M, Serra-Baldrich, E, Simon, D, Szalai, ZZ, Szepietowski, JC, Torrelo, A, Werfel, T, Werner, RN, Flohr, C. European Guideline (EuroGuiDerm) on atopic eczema: Living update. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2025; 39(9)DOI:10.1111/jdv.20639. PMID:40317496. IF:8.000(Q1/1D).
01/09/2025
NfL and GFAP treatment-response serum biomarkers are influenced by elapsed time from MS onset to ocrelizumab initiation
Velasco, JIF, Jorge, FR, Monreal, E, Gracia, J, Díaz, EF, Meca-Lallana, V, Villarrubia, N, de la Maza, SS, Cortegana, EMP, Quiroga-Varela, A, Ramio-Torrentá, L, Martínez-Yélamos, S, Vila, LB, Real, AML, Romero, AR, Canelo, LB, Nicolas, SD, Eguia, P, Espiño, M, Garcia, JLC, Hernandez, FJB, González, JLV, Meca-Lallana, JE, Martos, PG, Gines, MLM, García-Dominguez, JM, Moreno, I, Sainz, R, Mañe, A, Rodriguez, ABC, Pinedo, FC, Labiano, A, Ayuso, L, Abreu, R, Hernández, MA, Rodríguez, MR, Martín-Aguilar, L, González, AH, Rojas, FJV, Cabredo, LF, Sanchez-Seco, VG, Muñoz, JS, Polo, LF, Castañon, IG, Moreno, SMG, Masjuan, J, Costa-Frossard, L, Guimerans, LMV. NfL and GFAP treatment-response serum biomarkers are influenced by elapsed time from MS onset to ocrelizumab initiation. Multiple Sclerosis Journal. 2025; 31(3)DOI:. PMID:. IF:5.000(Q1/2D).
01/09/2025
ADEM and other common radiological patterns shared in children with MOG-IgG and antibody-negative autoimmune encephalitis
Olivé-Cirera, G, Falcioni, L, Fetta, A, Perez, EGF, Verdaguer, MG, Martinez, E, Sabaté, L, Saiz, A, Dalmau, J, Armangue, T. ADEM and other common radiological patterns shared in children with MOG-IgG and antibody-negative autoimmune encephalitis. Multiple Sclerosis Journal. 2025; 31(3)DOI:. PMID:. IF:5.000(Q1/2D).
30/08/2025
Trends in Antituberculosis Drug Resistance and Associated Factors: A 31-Year Observational Study at a Tertiary Hospital in Barcelona
Espasa, M, Pagán, B, Fernández-Pittol, M, Orcau, A, Tudó, G, Garcia, F, Martinez, JA, Soler, N, Horvath-Ruiz, L, San-Nicolás, L, Martinez, D, Casals-Pascual, C, Vila, J, Millet, JP, Caylà, JA, Gonzalez-Martin, J. Trends in Antituberculosis Drug Resistance and Associated Factors: A 31-Year Observational Study at a Tertiary Hospital in Barcelona. Antibiotics-Basel. 2025; 14(9)DOI:10.3390/antibiotics14090875. PMID:41009854. IF:4.600(Q1/2D).
30/08/2025
Effectiveness of CONFIVAC, an intervention to enhance paediatric nurses and paediatricians skills to promote vaccination: A mixed-methods cluster randomized trial
Roel, E, Henderson, E, Valmayor, S, Porthé, V, Asensio, A, Ramírez-Morros, A, Bruna, X, Pasarín, MI, Rius, C, Díez, E. Effectiveness of CONFIVAC, an intervention to enhance paediatric nurses and paediatricians skills to promote vaccination: A mixed-methods cluster randomized trial. VACCINE. 2025; 62DOI:10.1016/j.vaccine.2025.127603. PMID:40818260. IF:3.500(Q2/4D).
29/08/2025
Integrating Citizen Science and Field Sampling into Next-Generation Early-Warning Systems for Vector Surveillance: Twenty Years of Municipal Detections of Aedes Invasive Mosquito Species in Spain
Eritja, R, Sanpera-Calbet, I, Delacour-Estrella, S, Ruiz-Arrondo, I, Puig, MA, Bengoa-Paulis, M, Alarcón-Elbal, PM, Barceló, C, Mariani, S, Martinez-Barciela, Y, Bravo-Barriga, D, Polina, A, Pereira-Martinez, JM, González, MA, Escartin, S, Melero-Alcibar, R, Blanco-Sierra, L, Magallanes, S, Collantes, F, Ferraguti, M, González-Perez, MI, Gutierrez-López, R, Silva-Torres, MI, San Sebastián-Mendoza, O, Calvo-Reyes, MC, Mendoza-Garcia, M, Macias-Magro, D, Cisneros, P, Cevidanes, A, Frontera, E, Mato, I, Fúster-Lorán, F, Domench-Guembe, M, Rodriguez-Regadera, ME, Casanovas-Urgell, R, Montalvo, T, Miranda, MA, Figuerola, J, Lucientes-Curdi, J, Garriga, J, Palmer, JRB, Bartumeus, F. Integrating Citizen Science and Field Sampling into Next-Generation Early-Warning Systems for Vector Surveillance: Twenty Years of Municipal Detections of Aedes Invasive Mosquito Species in Spain. Insects. 2025; 16(9)DOI:10.3390/insects16090904. PMID:41009087. IF:2.900(Q1/2D).
27/08/2025
Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of frontotemporal dementia
Hok-A-Hin, YS, Vermunt, L, Peeters, CFW, van der Ende, EL, de Boer, SCM, Meeter, LH, de Houwer, J, Seelaar, H, van Swieten, JC, Hu, WT, Lleó, A, Alcolea, D, Engelborghs, S, Sieben, A, Chen-Plotkin, A, Irwin, DJ, van der Flier, WM, Pijnenburg, YAL, Teunissen, CE, del Campo, M. Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of frontotemporal dementia. Molecular Neurodegeneration. 2025; 20(1)DOI:10.1186/s13024-025-00882-5. PMID:40866991. IF:17.500(Q1/1D).
26/08/2025
Outcomes with esketamine nasal spray in patients with or without earlier partial or full response: post hoc analyses of ESCAPE TRD
Young, AH, Godinov, Y, Rive, B, Ito, T, Buyze, J, Oliveira-Maia, AJ, Fagiolini, A, Cardoner, N, Gorwood, P, Mcintyre, RS, Demyttenaere, K. Outcomes with esketamine nasal spray in patients with or without earlier partial or full response: post hoc analyses of ESCAPE TRD. EUROPEAN PSYCHIATRY. 2025; 68DOI:10.1192/j.eurpsy.2025.861. PMID:. IF:6.700(Q1/1D).
26/08/2025
Comparison of the effectiveness of first-line preventive treatment of migraine in primary care: study protocol for a pragmatic clinical trial (PREMI study)
Giner-Soriano, M, Morros, R, Monfà, R, Ouchi, D, Fernández-García, S, Vedia, C, Monné, SB, Martínez, EMC, Fanlo, SC, Morollón, N, Nieto, RB, Delgado-Espinoza, CE, García-Sangenís, A. Comparison of the effectiveness of first-line preventive treatment of migraine in primary care: study protocol for a pragmatic clinical trial (PREMI study). Trials. 2025; 26(1)DOI:10.1186/s13063-025-08961-0. PMID:40859286. IF:2.000(Q3/7D).
26/08/2025
Opening of a phase Ib/II study to investigate the safety and efficacy of Afatinib in patients with Fanconi anemia and unresectable locally advanced or metastatic head and neck squamous cell carcinoma
Anguera, G, Gallego, O, Llobet, M, Berga, N, Moreno-Martinez, ME, Leon, X, Kratz, C, Garcia-Escudero, R, Minguillón, J, Surrallés, J. Opening of a phase Ib/II study to investigate the safety and efficacy of Afatinib in patients with Fanconi anemia and unresectable locally advanced or metastatic head and neck squamous cell carcinoma. BMC CANCER. 2025; 25(1)DOI:10.1186/s12885-025-14619-6. PMID:40859225. IF:3.400(Q2/4D).
25/08/2025
Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models
Di Franco, N, de Tena, IB, Sanchez-Ruiz, A, Pereda-Velarde, A, Enfedaque, F, Gónzalez-Arias, C, Rio, LMM, Bortolozzi, A, Rodriguez-Puertas, R, Costas-Insua, C, Molina-Porcel, L, Vazquez-Oliver, A, Ozaita, A, Guzmán, M, Perea, G, Ginés, S. Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models. Translational Neurodegeneration. 2025; 14(1)DOI:10.1186/s40035-025-00500-w. PMID:40855505. IF:15.200(Q1/1D).
25/08/2025
Understanding the structure of insight in eating disorders: validation of the SAI-ED in a Spanish clinical sample
Gawron, LP, Garrido-Ribas, I, Carmona-Farrés, C, Carril-Batuecas, S, Carceller-Sindreu, M, Avila-Parcet, A, Amaro-Carriba, MA, Hernández-Molina, M, Portella, MJ, Pousa, E. Understanding the structure of insight in eating disorders: validation of the SAI-ED in a Spanish clinical sample. Journal of Eating Disorders. 2025; 13(1)DOI:10.1186/s40337-025-01360-5. PMID:40855569. IF:4.500(Q1/1D).
25/08/2025
Factors Involved in the Progression of Preclinical Atherosclerosis in People with Type 1 Diabetes
Viñals, C, Conget, I, Granados, M, Solà, C, Ayala, D, Mesa, A, Seres-Noriega, T, Domenech, M, Perea, V, Blanco, J, Vinagre, I, Gimenez, M, Amor, AJ. Factors Involved in the Progression of Preclinical Atherosclerosis in People with Type 1 Diabetes. Journal of Clinical Medicine. 2025; 14(17)DOI:10.3390/jcm14176004. PMID:40943764. IF:2.900(Q1/2D).
23/08/2025
Neural correlates of human fear conditioning and sources of variability in 2199 individuals
Radua, J, Savage, HS, Vilajosana, E, Jamieson, A, Abler, B, Åhs, F, Beckers, T, Cardoner, N, Cisler, JM, Diniz, JB, Bach, DR, Elsenbruch, S, Greening, SG, Holt, DJ, Kaczkurkin, AN, Keil, A, Kindt, M, Koch, K, LaBar, KS, Lam, CL, Larson, CL, Lonsdorf, TB, Merz, CJ, McLaughlin, KA, Neria, Y, Pine, DS, van Reekum, CM, Shackman, AJ, Soriano-Mas, C, Spoormaker, VI, Stout, DM, Straube, B, Straube, T, Tuominen, L, Visser, RM, Ahumada, L, Arolt, V, Batistuzzo, MC, Bazán, PR, Biggs, EE, Cano, M, Chavarría-Elizondo, P, Cooper, SE, Dannlowski, U, de la Peña-arteaga, V, Decross, SN, Domschke, K, Ehlers, MR, Graner, JL, Hamm, AO, Herrmann, MJ, Huggins, AA, Icenhour, A, Juaneda-Seguí, A, Junghoefer, M, Kircher, T, Koelkebeck, K, Kuhn, M, Labrenz, F, Lissek, SM, Lotze, M, Lueken, U, Margraf, J, Martínez-Zalacaín, I, Moeck, R, Morriss, J, Ortuño, M, Pittig, A, Porta-Casteras, D, Richter, J, Ridderbusch, IC, Rief, W, Roesmann, K, Rosén, J, Russmann, AN, Sjouwerman, R, Spohrs, J, Ströhle, A, Suarez-Jimenez, B, Ulrich, M, Wittchen, HU, Zhu, X, Waller, L, Walter, H, Thompson, PM, Bas-Hoogendam, JM, Groenewold, NA, Stein, DJ, van der Wee, NJ, Dunsmoor, JE, Marquand, AF, Harrison, BJ, Fullana, MA. Neural correlates of human fear conditioning and sources of variability in 2199 individuals. Nature Communications. 2025; 16(1)DOI:10.1038/s41467-025-63078-x. PMID:40849409. IF:15.700(Q1/1D).
22/08/2025
Reward-related neural activation during social media exposure in young women with non-suicidal self-injury: evidence for a continuum of severity in the reward network
Nicolaou, S, Julià, A, Otero, D, Schmidt, C, Pascual, JC, Soler, J, Marco-Pallarés, J, Vega, D. Reward-related neural activation during social media exposure in young women with non-suicidal self-injury: evidence for a continuum of severity in the reward network. Translational Psychiatry. 2025; 15(1)DOI:10.1038/s41398-025-03536-8. PMID:40846692. IF:6.200(Q1/1D).
22/08/2025
Transcriptomic Identification of Immune-Related Hubs as Candidate Predictor Biomarkers of Therapeutic Response in Psoriasis
Cantó, E, del Prado, ME, Vilarrasa, E, López-Ferrer, A, de Aranibar, FJGL, Ortiz, MA, Gut, M, Mulet, M, Esteve-Codina, A, Osuna-Gómez, R, Guinart-Cuadra, A, Puig, L, Vidal, S. Transcriptomic Identification of Immune-Related Hubs as Candidate Predictor Biomarkers of Therapeutic Response in Psoriasis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(17)DOI:10.3390/ijms26178118. PMID:40943056. IF:4.900(Q1/3D).
21/08/2025
Regional associations between cerebrovascular disease and cholinergic white matter pathways in the Lewy body continuum
Rennie, A, Nemy, M, Jerele, C, Rodríguez-Baz, I, Montal, V, Bejanin, A, Kramberger, MG, Aarsland, D, Fortea, J, Lleó, A, Westman, E, Alcolea, D, Ferreira, D. Regional associations between cerebrovascular disease and cholinergic white matter pathways in the Lewy body continuum. npj Parkinsons Disease. 2025; 11(1)DOI:10.1038/s41531-025-01118-5. PMID:40841717. IF:8.200(Q1/1D).
20/08/2025
Parkinson's disease medication adjustments based on wearable device information compared to other methods: randomized clinical trial
Rodríguez-Molinero, A, Pérez-López, C, Caballol, N, Buongiorno, M, Rivera, MAA, Ariztegui, NL, López-Manzanares, L, Hernández-Vara, J, Bayes-Rusiñol, A, Carreró, AG, Saúco, MA, Gomez, EF, Pérez-Martínez, DA, Arroyo, SE, Martí-Martínez, S, Mir, P, Juan, JMS, Martínez-Castrillo, JC, Tebé, C. Parkinson's disease medication adjustments based on wearable device information compared to other methods: randomized clinical trial. npj Parkinsons Disease. 2025; 11(1)DOI:10.1038/s41531-025-00977-2. PMID:40835832. IF:8.200(Q1/1D).
20/08/2025
Prepandemic levels of cytokines and immunoglobulins and risk of SARS-CoV-2 infection and COVID-19 in the general population of Barcelona
Porta, M, Pumarega, J, Aguilar, R, Prieto-Merino, D, Campi, L, Rius, C, Villar-García, J, Vidal, M, Jimenez, A, Peña, A, Muñoz, MA, Trasande, L, Bolúmar, F, Moncunill, G, Gasull, M, Dobaño, C. Prepandemic levels of cytokines and immunoglobulins and risk of SARS-CoV-2 infection and COVID-19 in the general population of Barcelona. Frontiers in Public Health. 2025; 13DOI:10.3389/fpubh.2025.1548456. PMID:40910046. IF:3.400(Q1/2D).
19/08/2025
Mapping cross-modal functional connectivity of major neurotransmitter systems in the human brain
Saiz-Masvidal, C, De la Peña-Arteaga, V, Bertolín, S, Diez, I, Juaneda-Seguí, A, Martínez-Zalacaín, I, Chavarría-Elizondo, P, Subirà, M, Menchón, JM, Sepulcre, J, Fullana, MA, Soriano-Mas, C. Mapping cross-modal functional connectivity of major neurotransmitter systems in the human brain. Brain Structure & Function. 2025; 230(7)DOI:10.1007/s00429-025-02996-4. PMID:40828212. IF:2.900(Q1/1D).
19/08/2025
Established and Emerging Roles of Epigenetic Regulation in Diabetic Cardiomyopathy
Russell-Hallinan, A, Karuna, N, Lezoualc'h, F, Matullo, G, Baker, H, Bernard, M, Devaux, Y, Badimon, L, Vilahur, G, Rieusset, J, Derumeaux, GA, Watson, CJ. Established and Emerging Roles of Epigenetic Regulation in Diabetic Cardiomyopathy. DIABETES-METABOLISM RESEARCH AND REVIEWS. 2025; 41(6)DOI:10.1002/dmrr.70081. PMID:40831067. IF:6.000(Q1/2D).
18/08/2025
The effectiveness of core stability exercises on functional outcomes in early subacute stroke recovery: a randomized controlled trial
Cabanas-Valdés, R, Boix-Sala, L, Ferrer-Solà, M, Grau-Pellicer, M, Gracia-Pi, N, Torrella-Vivó, N, Morales-Zafra, M, Esteve-Hernández, E, Guzmán-Bernal, JA, Caballero-Gómez, FM, Molina-Hervás, B, González-Hoelling, S, Lobato-Bonilla, A, López-de-Celis, C, Cánovas, E, Urrútia, G. The effectiveness of core stability exercises on functional outcomes in early subacute stroke recovery: a randomized controlled trial. Topics in Stroke Rehabilitation. 2025; 32(6)DOI:10.1080/10749357.2024.2439712. PMID:39742466. IF:2.500(Q1/2D).
18/08/2025
Integrating Global Surveillance, Local Action, and Innovative Stewardship Against Antimicrobial Resistance
Ruiz-Ramos, J. Integrating Global Surveillance, Local Action, and Innovative Stewardship Against Antimicrobial Resistance. Antibiotics-Basel. 2025; 14(8)DOI:10.3390/antibiotics14080835. PMID:40868029. IF:4.600(Q1/2D).
16/08/2025
Preventing Cisplatin-Induced Neuropathy and Related Emotional Disorders with the Coadministration of Duloxetine and Hydrogen-Rich Water in Male and Female Mice
Martínez-Martel, I, Negrini-Ferrari, SE, Pol, O. Preventing Cisplatin-Induced Neuropathy and Related Emotional Disorders with the Coadministration of Duloxetine and Hydrogen-Rich Water in Male and Female Mice. Antioxidants. 2025; 14(8)DOI:10.3390/antiox14081004. PMID:40867900. IF:6.600(Q1/1D).
16/08/2025
First-Trimester Clinical Characteristics and Pregnancy Outcomes in Women with Recurrent Pregnancy Loss
Trilla, C, Platero, J, Camprubí, N, Mora, J, Luna, C, Oros, D, Llurba, E. First-Trimester Clinical Characteristics and Pregnancy Outcomes in Women with Recurrent Pregnancy Loss. Journal of Clinical Medicine. 2025; 14(16)DOI:10.3390/jcm14165797. PMID:40869625. IF:2.900(Q1/2D).
14/08/2025
A Phase I Dose Escalation and Cohort Expansion Study of CB307, a Trispecific Humabody against PSMA, CD137, and Albumin in Patients with PSMA-Positive Solid Tumors
de Bono, JS, Williams, A, Melero, I, Jayaram, A, Hawley, JE, de Speville, BD, Moreno, I, Castellano, D, Reig, O, Knapen, DG, Anguera, G, Martinez, J, Gort, E, de Jonge, M, Alonso-Romero, JL, Boni, V, Perez-Gracia, JL, Falcon, A, de Groot, DJ, Pierce, AJ, Leishman, AJ, Lloyd, P, Bartlett, PD, Bland-Ward, P, Chau, A, Song, MJ, Duffy, K, Hashimoto, K, de Vries, E. A Phase I Dose Escalation and Cohort Expansion Study of CB307, a Trispecific Humabody against PSMA, CD137, and Albumin in Patients with PSMA-Positive Solid Tumors. CLINICAL CANCER RESEARCH. 2025; 31(16)DOI:10.1158/1078-0432.CCR-24-3581. PMID:40094417. IF:10.200(Q1/1D).
12/08/2025
Mobile Stroke Units An Investment, Not a Luxury
Ossa, NPD. Mobile Stroke Units An Investment, Not a Luxury. NEUROLOGY. 2025; 105(3)DOI:10.1212/WNL.0000000000213960. PMID:40627816. IF:8.500(Q1/1D).
12/08/2025
Update on the Prevalence, Incidence, Mortality, and Trends in Treatment of Inflammatory Bowel Disease in a Population-Based Registry in Catalonia Between 2017 and 2023
Brunet-Mas, E, Garcia-Sagué, B, Vela, E, Pontes, C, Melcarne, L, Frisancho, LE, Llovet, LP, Pedregal-Pascual, P, Lario, S, Ramírez-Lázaro, MJ, Villoria, A, Calvet, X. Update on the Prevalence, Incidence, Mortality, and Trends in Treatment of Inflammatory Bowel Disease in a Population-Based Registry in Catalonia Between 2017 and 2023. Journal of Clinical Medicine. 2025; 14(16)DOI:10.3390/jcm14165711. PMID:40869536. IF:2.900(Q1/2D).
12/08/2025
Advancements and challenges in pediatric dilated cardiomyopathy: a comprehensive review of current approaches and future directions
López-Guillén, JL, Esmel-Vilomara, R, Rodoman, I, Constante, AD, Kendall, S, Freixa-Benavente, A, Diaz-Gil, D, Cantarutti, N, Moscatelli, S, Jeewa, A. Advancements and challenges in pediatric dilated cardiomyopathy: a comprehensive review of current approaches and future directions. EUROPEAN JOURNAL OF PEDIATRICS. 2025; 184(9)DOI:10.1007/s00431-025-06263-w. PMID:40794194. IF:2.600(Q1/2D).
12/08/2025
Gene Expression Pattern Associated with Cytoskeletal Remodeling in Lipid-Loaded Human Vascular Smooth Muscle Cells: Crosstalk Between C3 Complement and the Focal Adhesion Protein Paxillin
Garcia-Arguinzonis, M, Escate, R, Lugano, R, Peña, E, Borrell-Pages, M, Badimon, L, Padro, T. Gene Expression Pattern Associated with Cytoskeletal Remodeling in Lipid-Loaded Human Vascular Smooth Muscle Cells: Crosstalk Between C3 Complement and the Focal Adhesion Protein Paxillin. Cells. 2025; 14(16)DOI:10.3390/cells14161245. PMID:40862724. IF:5.200(Q2/3D).
11/08/2025
Expanding the clinical-radiological phenotype of SCA34 and its role in the differential diagnosis of the hot cross bun sign
Olmedo-Saura, G, Iruzubieta, P, Bernal, S, Gonzalez-Quereda, L, Pont-Sunyer, C, Navalpotro-Gómez, I, Guisado-Alonso, D, García-Sanchez, C, Rodriguez-Santiago, B, Brais, B, Pagonabarraga, J, Kulisevsky, J, Pérez-Pérez, J. Expanding the clinical-radiological phenotype of SCA34 and its role in the differential diagnosis of the hot cross bun sign. JOURNAL OF NEUROLOGY. 2025; 272(9)DOI:10.1007/s00415-025-13316-5. PMID:40788501. IF:4.600(Q1/2D).
11/08/2025
Validation and normative data for the BAC app in Spanish-speaking individuals with psychosis and healthy controls
González-Blanch, C, Pousa, E, Reguera-Pozuelo, P, Gutiérrez-Zotes, A, Rodriguez-Jimenez, R, del-Castillo-Serrano, M, González-Pinto, A, Cano-Escalera, G, Zubia, M, Sánchez-Ortí, JV, Correa-Ghisays, P, Balanzá-Martínez, V, López-Carrilero, R, Bobes-Bascarán, T, Catalán, A, Aymerich, C, Díaz-Mandado, O, Guinart, D, Vilella, E, García-Alvarez, L, Ochoa, S, Miret, S, Falip, C, Fernández-Martínez, R, García-Cabeza, I, Campos-Rodriguez, C, Crosas, JM, Cobo, J, Pardina-Torner, H, Perona-Garcelán, S, Yorca-Ruiz, A, de la Foz, VOG, Ayesa-Arriola, R. Validation and normative data for the BAC app in Spanish-speaking individuals with psychosis and healthy controls. EUROPEAN PSYCHIATRY. 2025; 68(1)DOI:10.1192/j.eurpsy.2025.10076. PMID:40785579. IF:6.700(Q1/1D).
08/08/2025
The Role of Pharmacogenetic Biomarkers in Pain
da Silva, IM, Plaza-Díaz, A, Ruiz-Ramos, J, Juanes-Borrego, A, Riera, P. The Role of Pharmacogenetic Biomarkers in Pain. Biomedicines. 2025; 13(8)DOI:10.3390/biomedicines13081935. PMID:40868188. IF:3.900(Q1/3D).
07/08/2025
Development and assessment of an online communication skills course to optimise antibiotic prescribing for children in primary care
Arias-Alonso, L, Barragán-Brun, N, Elizondo-Alzola, U, Boldu-Minguell, A, Rocha-Calderón, CA, Niño-de-Guzmán, E, Santandreu, FM, Quesada-Carrasco, F, Ricci-Cabello, I, Gorrotxategi-Gorrotxategi, PJ, de la Poza-abad, M, Mas-Dalmau, G, Gibert-Agulló, A, González-Lama, J, Alonso-Coello, P. Development and assessment of an online communication skills course to optimise antibiotic prescribing for children in primary care. Bmc Primary Care. 2025; 26(1)DOI:10.1186/s12875-025-02919-6. PMID:40775754. IF:2.600(Q1/1D).
05/08/2025
Aortic Aneurysm Risk and the Somatic JAK2 V617F Mutation: Insights From a Multicenter, Population-Based Cardiovascular Screening Study
Obel, LM, Skovbo, JS, Diederichsen, ACP, Thomassen, M, Kjær, L, Larsen, MK, Knudsen, TA, Skov, V, Kruse, TA, Burton, M, Dembic, M, Wienecke, T, Sabater-Lleal, M, Gerke, O, Bruun, NE, Ellervik, C, Brabrand, M, Steffensen, FH, Frost, L, Lambrechtsen, J, Busk, M, Urbonaviciene, G, Egstrup, K, Karon, M, Feddersen, S, Rasmussen, LM, Hasselbalch, HC, Lindholt, JS. Aortic Aneurysm Risk and the Somatic JAK2 V617F Mutation: Insights From a Multicenter, Population-Based Cardiovascular Screening Study. CIRCULATION. 2025; 152(5)DOI:10.1161/CIRCULATIONAHA.125.074002. PMID:40464064. IF:38.600(Q1/1D).
01/08/2025
HDL from patients with recent ischemic stroke and carotid atherosclerosis shows less antioxidant enzymes and more inflammatory potential than patients with asymptomatic carotid atherosclerosis
Puig, N, Camps-Renom, P, Lambea, A, Guasch-Jiménez, M, Solé, A, Rives, J, Sanchez-Quesada, JL, Benitez, S. HDL from patients with recent ischemic stroke and carotid atherosclerosis shows less antioxidant enzymes and more inflammatory potential than patients with asymptomatic carotid atherosclerosis. ATHEROSCLEROSIS. 2025; 407DOI:. PMID:. IF:5.700(Q1/1D).
01/08/2025
Efficacy and safety of mechanical thrombectomy in acute ischaemic stroke secondary to infective endocarditis
Lapeña, P, Urra, X, Llopis, J, Hernández-Meneses, M, Cuervo, G, Maisterra, O, Escrihuela-Vidal, F, Prats-Sánchez, L, Sáez, C, Olmos, C, Hernández-Fernández, F, Werner, M, de la Ossa, NP, Quintana, E, Moreno, A, Chamorro, A, Miró, JM. Efficacy and safety of mechanical thrombectomy in acute ischaemic stroke secondary to infective endocarditis. CLINICAL MICROBIOLOGY AND INFECTION. 2025; 31(8)DOI:10.1016/j.cmi.2025.02.008. PMID:39924109. IF:8.500(Q1/1D).
01/08/2025
Switching Enzyme Replacement Therapy for Late-Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPEL
Kushlaf, H, Díaz-Manera, J, Bratkovic, D, Byrne, BJ, Claeys, KG, Clemens, PR, Dimachkie, MM, Kishnani, PS, Laforêt, P, Roberts, M, Schoser, B, Toscano, A, Castelli, J, Holdbrook, F, Das, SS, Goldman, M, Mozaffar, T. Switching Enzyme Replacement Therapy for Late-Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPEL. MUSCLE & NERVE. 2025; 72(2)DOI:10.1002/mus.28420. PMID:40342075. IF:3.100(Q2/4D).
01/08/2025
CSF Biomarker-Based Cognitive Trajectories in Parkinson's Disease-Subjective Cognitive Decline
Rodriguez-Antiguedad, J, Puig-Davi, A, Ruíz-Barrio, I, Pagonabarraga, J, Vázquez-Oliver, A, Horta-Barba, A, Kulisevsky, J, Martínez-Horta, S. CSF Biomarker-Based Cognitive Trajectories in Parkinson's Disease-Subjective Cognitive Decline. Annals of Clinical and Translational Neurology. 2025; 12(8)DOI:10.1002/acn3.70075. PMID:40501082. IF:3.900(Q1/3D).
01/08/2025
Targeting hallucinations in schizophrenia: Improving research translation into clinical practice
Corripio, I, Roldán, A. Targeting hallucinations in schizophrenia: Improving research translation into clinical practice. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2025; 97DOI:10.1016/j.euroneuro.2025.05.005. PMID:40409235. IF:6.700(Q1/1D).